Targeted for destruction: the molecular basis for development of novel therapeutic strategies in renal cell cancer.
Srinivasan
Ramaprasad
R
Linehan
W Marston
WM
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology*; D061945:Caspase Inhibitors; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology*; D008928:Mitochondria / Q000201:enzymology
D000970:Antineoplastic Agents; D061945:Caspase Inhibitors; D004791:Enzyme Inhibitors